Exercise of Warrants and Total Voting Rights
14/02/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230214:nRSN7889Pa&default-theme=true
RNS Number : 7889P S-Ventures PLC 14 February 2023
14 February 2023
S-VENTURES PLC
("S-Ventures" or the "Company")
Exercise of Warrants and Total Voting Rights
S-Ventures plc (AQSE: SVEN) (OTCQB: SVTPF), the enterprise company investing
in and growing exciting brands across the natural, wellness and food-tech
categories, is pleased to announce that it has received notifications from
warrantholder to exercise a total of 243,900 warrants, of which 237,800
warrants were exercised at 2 pence per warrant and 6,100 warrants were
exercised at 4 pence per warrant, raising a total of £5,000.00 for the
Company.
Admission
Application has been made for the 243,900 new ordinary shares, which will rank
pari passu with the existing ordinary shares in issue, to be admitted to
trading on the Aquis Stock Exchange Growth Market ("Admission"). Admission is
expected to occur at 8:00 a.m. on 17 February 2023.
Total Voting Rights
Following the issuance of the 243,900 new ordinary shares, the issued share
capital of the Company will be 132,215,587 Ordinary Shares. This figure may be
used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interests in, or changes
to their interests in, the Company under the FCA's Disclosure and Transparency
Rules.
For further information, please contact:
The Company +44 (0) 1932 400 224
Robert Hewitt (Chief Financial Officer)
Scott Livingston (Chief Executive Officer)
AQSE Corporate Adviser and Broker: +44 (0) 20 3005 5000
VSA Capital Limited
Andrew Raca
Evon Chan
IFC Advisory (Financial PR) +44 (0) 20 3934 6630
Graham Herring
Tim Metcalfe
Florence Chandler
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXGPUMAPUPWGBW